357 related articles for article (PubMed ID: 35078435)
21. Identification and validation of key genes associated with non-small-cell lung cancer.
Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
[TBL] [Abstract][Full Text] [Related]
22. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C
BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325
[TBL] [Abstract][Full Text] [Related]
23. Circadian clock associates with tumor microenvironment in thoracic cancers.
Yang Y; Yuan G; Xie H; Wei T; Zhu D; Cui J; Liu X; Shen R; Zhu Y; Yang X
Aging (Albany NY); 2019 Dec; 11(24):11814-11828. PubMed ID: 31881010
[TBL] [Abstract][Full Text] [Related]
24. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
25. TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway and promoting the epithelial mesenchymal transition.
Liu SL; Lin HX; Lin CY; Sun XQ; Ye LP; Qiu F; Wen W; Hua X; Wu XQ; Li J; Song LB; Guo L
Cancer Lett; 2017 Aug; 402():117-130. PubMed ID: 28583847
[TBL] [Abstract][Full Text] [Related]
26. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
27. Identification of circadian clock genes as regulators of immune infiltration in Hepatocellular Carcinoma.
Zhang Z; Liang Z; Gao W; Yu S; Hou Z; Li K; Zeng P
J Cancer; 2022; 13(11):3199-3208. PubMed ID: 36118525
[No Abstract] [Full Text] [Related]
28. A Comprehensive Bioinformatic Analysis for Identification of Myeloid-Associated Differentiation Marker as a Potential Negative Prognostic Biomarker in Non-Small-Cell Lung Cancer.
Zhou M; Chen Y; Gu X; Wang C
Pathol Oncol Res; 2022; 28():1610504. PubMed ID: 36061144
[No Abstract] [Full Text] [Related]
29. Identification and Prognostic Value Exploration of Radiotherapy Sensitivity-Associated Genes in Non-Small-Cell Lung Cancer.
Ma Q; Geng K; Xiao P; Zeng L
Biomed Res Int; 2021; 2021():5963868. PubMed ID: 34518802
[TBL] [Abstract][Full Text] [Related]
30. Glucose restriction induces AMPK-SIRT1-mediated circadian clock gene Per expression and delays NSCLC progression.
Li B; Chen Q; Feng Y; Wei T; Zhong Y; Zhang Y; Feng Q
Cancer Lett; 2023 Nov; 576():216424. PubMed ID: 37778683
[TBL] [Abstract][Full Text] [Related]
31. Expression Signature and Role of miR-30d-5p in Non-Small Cell Lung Cancer: a Comprehensive Study Based on in Silico Analysis of Public Databases and in Vitro Experiments.
Gao L; He RQ; Wu HY; Zhang TT; Liang HW; Ye ZH; Li ZY; Xie TT; Shi Q; Ma J; Hu XH; Chen G
Cell Physiol Biochem; 2018; 50(5):1964-1987. PubMed ID: 30396166
[TBL] [Abstract][Full Text] [Related]
32. Identification of Deleterious
Zhang K; Hong X; Song Z; Xu Y; Li C; Wang G; Zhang Y; Zhao X; Zhao Z; Zhao J; Huang M; Huang D; Qi C; Gao C; Cai S; Gu F; Hu Y; Xu C; Wang W; Lou Z; Zhang Y; Liu L
Clin Cancer Res; 2020 Jul; 26(14):3649-3661. PubMed ID: 32241817
[TBL] [Abstract][Full Text] [Related]
33. NCAPG is a prognostic biomarker of immune infiltration in non-small-cell lung cancer.
Zhou Y; Fan Y; Mao Y; Lou M; Liu X; Yuan K; Tong J
Biomark Med; 2022 May; 16(7):523-535. PubMed ID: 35199566
[No Abstract] [Full Text] [Related]
34. Disruptions of Circadian Genes in Cutaneous Melanoma-An In Silico Analysis of Transcriptome Databases.
Lesicka M; Nedoszytko B; Reszka E
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373286
[TBL] [Abstract][Full Text] [Related]
35. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
[TBL] [Abstract][Full Text] [Related]
36. High expression of MYEOV reflects poor prognosis in non-small cell lung cancer.
Zhang R; Ma A
Gene; 2021 Feb; 770():145337. PubMed ID: 33278551
[TBL] [Abstract][Full Text] [Related]
37. TIMELESS mutation alters phase responsiveness and causes advanced sleep phase.
Kurien P; Hsu PK; Leon J; Wu D; McMahon T; Shi G; Xu Y; Lipzen A; Pennacchio LA; Jones CR; Fu YH; Ptáček LJ
Proc Natl Acad Sci U S A; 2019 Jun; 116(24):12045-12053. PubMed ID: 31138685
[TBL] [Abstract][Full Text] [Related]
38. ERK-mediated TIMELESS expression suppresses G2/M arrest in colon cancer cells.
Neilsen BK; Frodyma DE; McCall JL; Fisher KW; Lewis RE
PLoS One; 2019; 14(1):e0209224. PubMed ID: 30629587
[TBL] [Abstract][Full Text] [Related]
39. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.
Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB
Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608
[TBL] [Abstract][Full Text] [Related]
40. Loss of circadian clock gene expression is associated with tumor progression in breast cancer.
Cadenas C; van de Sandt L; Edlund K; Lohr M; Hellwig B; Marchan R; Schmidt M; Rahnenführer J; Oster H; Hengstler JG
Cell Cycle; 2014; 13(20):3282-91. PubMed ID: 25485508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
